Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
about
Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unitRole of prophylactic surgical ligation of patent ductus arteriosus in extremely low birth weight infants: Systematic review and implications for clinical practiceRegulation of the fetal mouse ductus arteriosus is dependent on interaction of nitric oxide and COX enzymes in the ductal wall.A preliminary study of the application of the transductal velocity ratio for assessing persistent ductus arteriosus.Inhibition of cyclooxygenase isoforms in late- but not midgestation decreases contractility of the ductus arteriosus and prevents postnatal closure in mice.Indomethacin use for the management of patent ductus arteriosus in preterms: a web-based survey of practice attitudes among neonatal fellowship program directors in the United States.Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse.Primary bronchomalacia and patent ductus arteriosus: simultaneous surgical correction in an infantB-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infantsPatent ductus arteriosus: an overviewA high ductal flow velocity is associated with successful pharmacological closure of patent ductus arteriosus in infants 22-27 weeks gestational age.The persistently patent arterial duct in the premature infant.Long-term results of transcatheter closure of patent ductus arteriosus in infants using amplatzer duct occluder.
P2860
Q24604121-85FC81B8-6224-4895-BB44-1919E5E5968DQ24631088-674056E3-B686-4715-8B36-CA8918E2197BQ30492927-9625C9F7-26E2-4512-AB71-AC276FF20148Q30495133-B847C931-CCEB-4381-A161-DCD2AC2288ACQ33644543-E9652382-9E37-4691-8D23-CE9483843F4FQ34846410-B78CD356-FA7E-46F9-8B33-497FB76BED91Q35214960-D56C093B-5B6D-4401-B854-86D21F7651CDQ35667640-CBB9283A-862A-44C4-B356-157B0082EF81Q35866715-F542736E-F8E9-4FD7-8E49-80122FEF0F58Q36290879-E550C87E-89C3-44F4-BEFE-EF76F59D3051Q36505035-1FB85A1E-E136-4455-A809-46F70531F2C4Q39652304-067D7033-F115-4B7F-B90D-924318F7C1C3Q41855708-455BE50F-1510-4915-A3FE-8F061B5043DD
P2860
Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Patent ductus arteriosus. Clin ...... pathophysiology and treatment.
@en
type
label
Patent ductus arteriosus. Clin ...... pathophysiology and treatment.
@en
prefLabel
Patent ductus arteriosus. Clin ...... pathophysiology and treatment.
@en
P1476
Patent ductus arteriosus. Clin ...... pathophysiology and treatment.
@en
P2093
Hammerman C
P304
P577
1995-06-01T00:00:00Z